Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17257949 | 1.00 | KDM4C (0.56) | KDM4CSIGMAR1CA1CA2 | |
| Hydrochloric Acid SCHEMBL9326664 | 0.85 | SIGMAR1 (0.55) | KDM4CSIGMAR1CA1CA2 | |
| Hydrochloric Acid SCHEMBL8815857 | 0.85 | SIGMAR1 (0.55) | KDM4CSIGMAR1CA1CA2 | |
| Hydrochloric Acid SCHEMBL9521770 | 0.83 | SIGMAR1 (0.56) | KDM4CSIGMAR1 | |
| SCHEMBL9520305 | 0.82 | SIGMAR1 (0.55) | KDM4CSIGMAR1CA1CA2 | |
| SCHEMBL15839894 | 0.80 | SIGMAR1 (0.57) | SIGMAR1CA1CA2 | |
| SCHEMBL8019430 | 0.80 | SIGMAR1 (0.57) | SIGMAR1 | |
| SCHEMBL8811492 | 0.80 | SIGMAR1 (0.57) | SIGMAR1 | |
| SCHEMBL9549201 | 0.80 | SIGMAR1 (0.57) | SIGMAR1CA1CA2 | |
| SCHEMBL15286771 | 0.80 | SIGMAR1 (0.57) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9686985-B2 | Fungicide N-cycloalkyl-N-bicyclicmethylene-carboxamide derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-06-27 | — | — | US | claimed |
| US-20160366885-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH | 2016-12-22 | — | — | US | claimed |
| US-9233929-B2 | Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-01-12 | — | — | US | claimed |
| US-20150327548-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-11-19 | — | — | US | claimed |
| EP-2831048-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | Bayer Intellectual Property GmbH (DE) | 2015-02-04 | — | — | EP | claimed |
| WO-2013144086-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-10-03 | — | — | WO | claimed |
| US-20130102790-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG | 2013-04-25 | — | — | US | claimed |
| EP-2391608-B1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2013-03-06 | — | — | EP | claimed |
| EP-2391608-A1 | Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives | Bayer CropScience AG (DE) | 2011-12-07 | — | — | EP | claimed |
| US-20110294863-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2011-12-01 | — | — | US | claimed |
| WO-2010086311-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-08-05 | — | — | WO | claimed |
| US-9686985-B2 | Fungicide N-cycloalkyl-N-bicyclicmethylene-carboxamide derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-06-27 | — | — | US | disclosed |
| EP-2831048-B1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2017-04-26 | — | — | EP | disclosed |
| US-20160366885-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH | 2016-12-22 | — | — | US | disclosed |
| US-9468211-B2 | Fungicide N-cycloalkyl-N-bicyclicmethylene-carboxamide derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-10-18 | — | — | US | disclosed |
| EP-2391608-B1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2013-03-06 | — | — | EP | disclosed |
| US-8349884-B2 | Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2013-01-08 | — | — | US | disclosed |
| EP-2391608-A1 | Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives | Bayer CropScience AG (DE) | 2011-12-07 | — | — | EP | disclosed |
| US-20110294863-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2011-12-01 | — | — | US | disclosed |
| WO-2010086311-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160366885-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | CBR3, CNPY2, CYP51A1 | KDM4C 362/4885SIGMAR1 3236/4885CA1 2140/4885 |
| US-20150327548-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLICMETHYLENE-CARBOXAMIDE DERIVATIVES | CBR3, CNPY2, CYP51A1 | KDM4C 362/4885SIGMAR1 3236/4885CA1 2140/4885 |
| US-20110294863-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIMETHYLENE-CARBOXAMIDE DERIVATIVES | CBR3, CBR1, CNPY2 | KDM4C 580/4885SIGMAR1 2118/4885CA1 1147/4885 |
| US-20130102790-A1 | FUNGICIDE N-CYCLOALKYL-N-BICYCLIMETHYLENE-CARBOXAMIDE DERIVATIVES | CBR3, CBR1, CNPY2 | KDM4C 727/4885SIGMAR1 1739/4885CA1 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.